APO Research
Talk to an analyst

APO RESEARCH · REPORT

T Cell Surface Glycoprotein CD3 Epsilon

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global T Cell Surface Glycoprotein CD3 Epsilon Industry Growth and Trends Forecast to 2032

19 December 202589 pages

Choose your research edition.

Industry ResearchT Cell Surface Glycoprotein CD3 Epsilon Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal T Cell Surface Glycoprotein CD3 Epsilon Industry Growth and Trends Forecast to 203289 pages · $3,450 USDMarket StructureGlobal T Cell Surface Glycoprotein CD3 Epsilon Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal T Cell Surface Glycoprotein CD3 Epsilon Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal T Cell Surface Glycoprotein CD3 Epsilon Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

According to APO Research, the global T Cell Surface Glycoprotein CD3 Epsilon market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for T Cell Surface Glycoprotein CD3 Epsilon is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for T Cell Surface Glycoprotein CD3 Epsilon is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for T Cell Surface Glycoprotein CD3 Epsilon is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the T Cell Surface Glycoprotein CD3 Epsilon market include GlaxoSmithKline Plc, Amgen Inc, Tiziana Life Sciences Plc, SYNIMMUNE GmbH, Numab Innovation AG, Meridigen Biotech Co Ltd, MacroGenics Inc, F. Hoffmann-La Roche Ltd and Celgene Corp, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global T Cell Surface Glycoprotein CD3 Epsilon market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The T Cell Surface Glycoprotein CD3 Epsilon market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global T Cell Surface Glycoprotein CD3 Epsilon market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to T Cell Surface Glycoprotein CD3 Epsilon.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global T Cell Surface Glycoprotein CD3 Epsilon market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

T Cell Surface Glycoprotein CD3 Epsilon Market by Company

GlaxoSmithKline Plc

Amgen Inc

Tiziana Life Sciences Plc

SYNIMMUNE GmbH

Numab Innovation AG

Meridigen Biotech Co Ltd

MacroGenics Inc

F. Hoffmann-La Roche Ltd

Celgene Corp

T Cell Surface Glycoprotein CD3 Epsilon Segment by Type

ND-007

Foralumab

Coltelizumab

AVA-002

Others

T Cell Surface Glycoprotein CD3 Epsilon Segment by Application

Autoimmune Disorders

Hepatitis B

Prostate Cancer

Multiple Sclerosis

Others

T Cell Surface Glycoprotein CD3 Epsilon Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global T Cell Surface Glycoprotein CD3 Epsilon market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of T Cell Surface Glycoprotein CD3 Epsilon and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of T Cell Surface Glycoprotein CD3 Epsilon.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of T Cell Surface Glycoprotein CD3 Epsilon companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global T Cell Surface Glycoprotein CD3 Epsilon Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global T Cell Surface Glycoprotein CD3 Epsilon Market Size by Region (2021-2026) & (US$ Million) Table 3. Global T Cell Surface Glycoprotein CD3 Epsilon Market Share by Region (2021-2026) Table 4. Global T Cell Surface Glycoprotein CD3 Epsilon Market Size by Region (2027-2032) & (US$ Million) Table 5. Global T Cell Surface Glycoprotein CD3 Epsilon Market Share by Region (2027-2032) Table 6. Global T Cell Surface Glycoprotein CD3 Epsilon Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global T Cell Surface Glycoprotein CD3 Epsilon Market Size by Type (2021-2026) & (US$ Million) Table 8. Global T Cell Surface Glycoprotein CD3 Epsilon Market Size Share by Type (2021-2026) Table 9. Global T Cell Surface Glycoprotein CD3 Epsilon Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global T Cell Surface Glycoprotein CD3 Epsilon Market Size Share Forecasted by Type (2027-2032) Table 11. North America T Cell Surface Glycoprotein CD3 Epsilon Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America T Cell Surface Glycoprotein CD3 Epsilon Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe T Cell Surface Glycoprotein CD3 Epsilon Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe T Cell Surface Glycoprotein CD3 Epsilon Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific T Cell Surface Glycoprotein CD3 Epsilon Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific T Cell Surface Glycoprotein CD3 Epsilon Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America T Cell Surface Glycoprotein CD3 Epsilon Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America T Cell Surface Glycoprotein CD3 Epsilon Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa T Cell Surface Glycoprotein CD3 Epsilon Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa T Cell Surface Glycoprotein CD3 Epsilon Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global T Cell Surface Glycoprotein CD3 Epsilon Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global T Cell Surface Glycoprotein CD3 Epsilon Market Size by Application (2021-2026) & (US$ Million) Table 23. Global T Cell Surface Glycoprotein CD3 Epsilon Market Size Share by Application (2021-2026) Table 24. Global T Cell Surface Glycoprotein CD3 Epsilon Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global T Cell Surface Glycoprotein CD3 Epsilon Market Size Share Forecasted by Application (2027-2032) Table 26. North America T Cell Surface Glycoprotein CD3 Epsilon Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America T Cell Surface Glycoprotein CD3 Epsilon Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe T Cell Surface Glycoprotein CD3 Epsilon Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe T Cell Surface Glycoprotein CD3 Epsilon Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific T Cell Surface Glycoprotein CD3 Epsilon Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific T Cell Surface Glycoprotein CD3 Epsilon Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America T Cell Surface Glycoprotein CD3 Epsilon Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America T Cell Surface Glycoprotein CD3 Epsilon Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa T Cell Surface Glycoprotein CD3 Epsilon Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa T Cell Surface Glycoprotein CD3 Epsilon Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. T Cell Surface Glycoprotein CD3 Epsilon Industry Trends Table 37. T Cell Surface Glycoprotein CD3 Epsilon Industry Drivers Table 38. T Cell Surface Glycoprotein CD3 Epsilon Industry Opportunities and Challenges Table 39. T Cell Surface Glycoprotein CD3 Epsilon Industry Restraints Table 40. Global T Cell Surface Glycoprotein CD3 Epsilon Revenue by Company (US$ Million) & (2021-2026) Table 41. Global T Cell Surface Glycoprotein CD3 Epsilon Revenue Market Share by Company (2021-2026) Table 42. Global T Cell Surface Glycoprotein CD3 Epsilon Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global T Cell Surface Glycoprotein CD3 Epsilon Key Company Headquarters & Area Served Table 44. Global T Cell Surface Glycoprotein CD3 Epsilon Company, Product Type & Application Table 45. Global T Cell Surface Glycoprotein CD3 Epsilon Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global T Cell Surface Glycoprotein CD3 Epsilon by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. GlaxoSmithKline Plc Company Information Table 49. GlaxoSmithKline Plc Business Overview Table 50. GlaxoSmithKline Plc T Cell Surface Glycoprotein CD3 Epsilon Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. GlaxoSmithKline Plc T Cell Surface Glycoprotein CD3 Epsilon Product Portfolio Table 52. GlaxoSmithKline Plc Recent Development Table 53. Amgen Inc Company Information Table 54. Amgen Inc Business Overview Table 55. Amgen Inc T Cell Surface Glycoprotein CD3 Epsilon Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Amgen Inc T Cell Surface Glycoprotein CD3 Epsilon Product Portfolio Table 57. Amgen Inc Recent Development Table 58. Tiziana Life Sciences Plc Company Information Table 59. Tiziana Life Sciences Plc Business Overview Table 60. Tiziana Life Sciences Plc T Cell Surface Glycoprotein CD3 Epsilon Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Tiziana Life Sciences Plc T Cell Surface Glycoprotein CD3 Epsilon Product Portfolio Table 62. Tiziana Life Sciences Plc Recent Development Table 63. SYNIMMUNE GmbH Company Information Table 64. SYNIMMUNE GmbH Business Overview Table 65. SYNIMMUNE GmbH T Cell Surface Glycoprotein CD3 Epsilon Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. SYNIMMUNE GmbH T Cell Surface Glycoprotein CD3 Epsilon Product Portfolio Table 67. SYNIMMUNE GmbH Recent Development Table 68. Numab Innovation AG Company Information Table 69. Numab Innovation AG Business Overview Table 70. Numab Innovation AG T Cell Surface Glycoprotein CD3 Epsilon Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Numab Innovation AG T Cell Surface Glycoprotein CD3 Epsilon Product Portfolio Table 72. Numab Innovation AG Recent Development Table 73. Meridigen Biotech Co Ltd Company Information Table 74. Meridigen Biotech Co Ltd Business Overview Table 75. Meridigen Biotech Co Ltd T Cell Surface Glycoprotein CD3 Epsilon Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Meridigen Biotech Co Ltd T Cell Surface Glycoprotein CD3 Epsilon Product Portfolio Table 77. Meridigen Biotech Co Ltd Recent Development Table 78. MacroGenics Inc Company Information Table 79. MacroGenics Inc Business Overview Table 80. MacroGenics Inc T Cell Surface Glycoprotein CD3 Epsilon Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. MacroGenics Inc T Cell Surface Glycoprotein CD3 Epsilon Product Portfolio Table 82. MacroGenics Inc Recent Development Table 83. F. Hoffmann-La Roche Ltd Company Information Table 84. F. Hoffmann-La Roche Ltd Business Overview Table 85. F. Hoffmann-La Roche Ltd T Cell Surface Glycoprotein CD3 Epsilon Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. F. Hoffmann-La Roche Ltd T Cell Surface Glycoprotein CD3 Epsilon Product Portfolio Table 87. F. Hoffmann-La Roche Ltd Recent Development Table 88. Celgene Corp Company Information Table 89. Celgene Corp Business Overview Table 90. Celgene Corp T Cell Surface Glycoprotein CD3 Epsilon Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Celgene Corp T Cell Surface Glycoprotein CD3 Epsilon Product Portfolio Table 92. Celgene Corp Recent Development Table 93. North America T Cell Surface Glycoprotein CD3 Epsilon Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 94. North America T Cell Surface Glycoprotein CD3 Epsilon Market Size by Country (2021-2026) & (US$ Million) Table 95. North America T Cell Surface Glycoprotein CD3 Epsilon Market Share by Country (2021-2026) Table 96. North America T Cell Surface Glycoprotein CD3 Epsilon Market Size Forecast by Country (2027-2032) & (US$ Million) Table 97. North America T Cell Surface Glycoprotein CD3 Epsilon Market Share Forecast by Country (2027-2032) Table 98. Europe T Cell Surface Glycoprotein CD3 Epsilon Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 99. Europe T Cell Surface Glycoprotein CD3 Epsilon Market Size by Country (2021-2026) & (US$ Million) Table 100. Europe T Cell Surface Glycoprotein CD3 Epsilon Market Share by Country (2021-2026) Table 101. Europe T Cell Surface Glycoprotein CD3 Epsilon Market Size Forecast by Country (2027-2032) & (US$ Million) Table 102. Europe T Cell Surface Glycoprotein CD3 Epsilon Market Share Forecast by Country (2027-2032) Table 103. Asia-Pacific T Cell Surface Glycoprotein CD3 Epsilon Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 104. Asia-Pacific T Cell Surface Glycoprotein CD3 Epsilon Market Size by Country (2021-2026) & (US$ Million) Table 105. Asia-Pacific T Cell Surface Glycoprotein CD3 Epsilon Market Share by Country (2021-2026) Table 106. Asia-Pacific T Cell Surface Glycoprotein CD3 Epsilon Market Size Forecast by Country (2027-2032) & (US$ Million) Table 107. Asia-Pacific T Cell Surface Glycoprotein CD3 Epsilon Market Share Forecast by Country (2027-2032) Table 108. Latin America T Cell Surface Glycoprotein CD3 Epsilon Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 109. Latin America T Cell Surface Glycoprotein CD3 Epsilon Market Size by Country (2021-2026) & (US$ Million) Table 110. Latin America T Cell Surface Glycoprotein CD3 Epsilon Market Share by Country (2021-2026) Table 111. Latin America T Cell Surface Glycoprotein CD3 Epsilon Market Size Forecast by Country (2027-2032) & (US$ Million) Table 112. Latin America T Cell Surface Glycoprotein CD3 Epsilon Market Share Forecast by Country (2027-2032) Table 113. Middle East & Africa T Cell Surface Glycoprotein CD3 Epsilon Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 114. Middle East & Africa T Cell Surface Glycoprotein CD3 Epsilon Market Size by Country (2021-2026) & (US$ Million) Table 115. Middle East & Africa T Cell Surface Glycoprotein CD3 Epsilon Market Share by Country (2021-2026) Table 116. Middle East & Africa T Cell Surface Glycoprotein CD3 Epsilon Market Size Forecast by Country (2027-2032) & (US$ Million) Table 117. Middle East & Africa T Cell Surface Glycoprotein CD3 Epsilon Market Share Forecast by Country (2027-2032) Table 118. Research Programs/Design for This Report Table 119. Authors List of This Report Table 120. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. T Cell Surface Glycoprotein CD3 Epsilon Product Image Figure 3. Global T Cell Surface Glycoprotein CD3 Epsilon Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global T Cell Surface Glycoprotein CD3 Epsilon Market Size (2021-2032) & (US$ Million) Figure 5. Global T Cell Surface Glycoprotein CD3 Epsilon Market Share by Region: 2025 VS 2032 Figure 6. Global T Cell Surface Glycoprotein CD3 Epsilon Market Share by Region (2021-2032) Figure 7. North America T Cell Surface Glycoprotein CD3 Epsilon Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe T Cell Surface Glycoprotein CD3 Epsilon Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific T Cell Surface Glycoprotein CD3 Epsilon Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America T Cell Surface Glycoprotein CD3 Epsilon Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa T Cell Surface Glycoprotein CD3 Epsilon Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. ND-007 Image Figure 13. Global ND-007 Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Foralumab Image Figure 15. Global Foralumab Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Coltelizumab Image Figure 17. Global Coltelizumab Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. AVA-002 Image Figure 19. Global AVA-002 Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Others Image Figure 21. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 22. Global T Cell Surface Glycoprotein CD3 Epsilon Market Size Overview by Type (2021-2032) & (US$ Million) Figure 23. Global T Cell Surface Glycoprotein CD3 Epsilon Market Share by Type 2025 VS 2032 Figure 24. North America T Cell Surface Glycoprotein CD3 Epsilon Market Size Share by Type (2021-2032) Figure 25. Europe T Cell Surface Glycoprotein CD3 Epsilon Market Size Share by Type (2021-2032) Figure 26. Asia-Pacific T Cell Surface Glycoprotein CD3 Epsilon Market Size Share by Type (2021-2032) Figure 27. Latin America T Cell Surface Glycoprotein CD3 Epsilon Market Size Share by Type (2021-2032) Figure 28. Middle East and Africa T Cell Surface Glycoprotein CD3 Epsilon Market Size Share by Type (2021-2032) Figure 29. Autoimmune Disorders Image Figure 30. Global Autoimmune Disorders Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Hepatitis B Image Figure 32. Global Hepatitis B Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Prostate Cancer Image Figure 34. Global Prostate Cancer Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Multiple Sclerosis Image Figure 36. Global Multiple Sclerosis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 37. Others Image Figure 38. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 39. Global T Cell Surface Glycoprotein CD3 Epsilon Market Size Overview by Application (2021-2032) & (US$ Million) Figure 40. Global T Cell Surface Glycoprotein CD3 Epsilon Market Share by Application 2025 VS 2032 Figure 41. North America T Cell Surface Glycoprotein CD3 Epsilon Market Size Share by Application (2021-2032) Figure 42. Europe T Cell Surface Glycoprotein CD3 Epsilon Market Size Share by Application (2021-2032) Figure 43. Asia-Pacific T Cell Surface Glycoprotein CD3 Epsilon Market Size Share by Application (2021-2032) Figure 44. Latin America T Cell Surface Glycoprotein CD3 Epsilon Market Size Share by Application (2021-2032) Figure 45. Middle East and Africa T Cell Surface Glycoprotein CD3 Epsilon Market Size Share by Application (2021-2032) Figure 46. Global Top 5 and 10 T Cell Surface Glycoprotein CD3 Epsilon Players Market Share by Revenue in 2025 Figure 47. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 48. North America T Cell Surface Glycoprotein CD3 Epsilon Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 49. North America T Cell Surface Glycoprotein CD3 Epsilon Market Share by Country: 2021 VS 2025 VS 2032 Figure 50. North America T Cell Surface Glycoprotein CD3 Epsilon Market Share by Country (2021-2032) Figure 51. Europe T Cell Surface Glycoprotein CD3 Epsilon Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe T Cell Surface Glycoprotein CD3 Epsilon Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe T Cell Surface Glycoprotein CD3 Epsilon Market Share by Country (2021-2032) Figure 54. Asia-Pacific T Cell Surface Glycoprotein CD3 Epsilon Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Asia-Pacific T Cell Surface Glycoprotein CD3 Epsilon Market Share by Country: 2021 VS 2025 VS 2032 Figure 56. Asia-Pacific T Cell Surface Glycoprotein CD3 Epsilon Market Share by Country (2021-2032) Figure 57. Latin America T Cell Surface Glycoprotein CD3 Epsilon Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America T Cell Surface Glycoprotein CD3 Epsilon Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America T Cell Surface Glycoprotein CD3 Epsilon Market Share by Country (2021-2032) Figure 60. Middle East & Africa T Cell Surface Glycoprotein CD3 Epsilon Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 61. Middle East & Africa T Cell Surface Glycoprotein CD3 Epsilon Market Share by Country: 2021 VS 2025 VS 2032 Figure 62. Middle East & Africa T Cell Surface Glycoprotein CD3 Epsilon Market Share by Country (2021-2032) Figure 63. Years Considered Figure 64. Research Process Figure 65. Key Executives Interviewed

Scope & coverage.

Types
  • ND-007
  • Foralumab
  • Coltelizumab
  • AVA-002
  • Others
Applications
  • Autoimmune Disorders
  • Hepatitis B
  • Prostate Cancer
  • Multiple Sclerosis
  • Others
Companies covered
  • GlaxoSmithKline Plc
  • Amgen Inc
  • Tiziana Life Sciences Plc
  • SYNIMMUNE GmbH
  • Numab Innovation AG
  • Meridigen Biotech Co Ltd
  • MacroGenics Inc
  • F. Hoffmann-La Roche Ltd
  • Celgene Corp

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global T Cell Surface Glycoprotein CD3 Epsilon Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global T Cell Surface Glycoprotein CD3 Epsilon Market Size by Region (2021-2032)
  5. 1.4.1 Global T Cell Surface Glycoprotein CD3 Epsilon Market Size by Region (2021-2026)
  6. 1.4.2 Global T Cell Surface Glycoprotein CD3 Epsilon Market Size by Region (2027-2032)
  7. 1.5 Key Regions T Cell Surface Glycoprotein CD3 Epsilon Market Size (2021-2032)
  8. 1.5.1 North America T Cell Surface Glycoprotein CD3 Epsilon Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe T Cell Surface Glycoprotein CD3 Epsilon Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific T Cell Surface Glycoprotein CD3 Epsilon Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America T Cell Surface Glycoprotein CD3 Epsilon Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa T Cell Surface Glycoprotein CD3 Epsilon Market Size Growth Rate (2021-2032)
2 T Cell Surface Glycoprotein CD3 Epsilon Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 ND-007
  3. 2.1.2 Foralumab
  4. 2.1.3 Coltelizumab
  5. 2.1.4 AVA-002
  6. 2.1.5 Others
  7. 2.2 Global T Cell Surface Glycoprotein CD3 Epsilon Market Size by Type
  8. 2.2.1 Global T Cell Surface Glycoprotein CD3 Epsilon Market Size Overview by Type (2021-2032)
  9. 2.2.2 Global T Cell Surface Glycoprotein CD3 Epsilon Historic Market Size Review by Type (2021-2026)
  10. 2.2.3 Global T Cell Surface Glycoprotein CD3 Epsilon Market Size Forecasted by Type (2027-2032)
  11. 2.3 Global T Cell Surface Glycoprotein CD3 Epsilon Market Size by Regions
  12. 2.3.1 North America T Cell Surface Glycoprotein CD3 Epsilon Market Size Breakdown by Type (2021-2026)
  13. 2.3.2 Europe T Cell Surface Glycoprotein CD3 Epsilon Market Size Breakdown by Type (2021-2026)
  14. 2.3.3 Asia-Pacific T Cell Surface Glycoprotein CD3 Epsilon Market Size Breakdown by Type (2021-2026)
  15. 2.3.4 South America T Cell Surface Glycoprotein CD3 Epsilon Market Size Breakdown by Type (2021-2026)
  16. 2.3.5 Middle East and Africa T Cell Surface Glycoprotein CD3 Epsilon Market Size Breakdown by Type (2021-2026)
3 T Cell Surface Glycoprotein CD3 Epsilon Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Autoimmune Disorders
  3. 3.1.2 Hepatitis B
  4. 3.1.3 Prostate Cancer
  5. 3.1.4 Multiple Sclerosis
  6. 3.1.5 Others
  7. 3.2 Global T Cell Surface Glycoprotein CD3 Epsilon Market Size by Application
  8. 3.2.1 Global T Cell Surface Glycoprotein CD3 Epsilon Market Size Overview by Application (2021-2032)
  9. 3.2.2 Global T Cell Surface Glycoprotein CD3 Epsilon Historic Market Size Review by Application (2021-2026)
  10. 3.2.3 Global T Cell Surface Glycoprotein CD3 Epsilon Market Size Forecasted by Application (2027-2032)
  11. 3.3 Global T Cell Surface Glycoprotein CD3 Epsilon Market Size by Regions
  12. 3.3.1 North America T Cell Surface Glycoprotein CD3 Epsilon Market Size Breakdown by Application (2021-2026)
  13. 3.3.2 Europe T Cell Surface Glycoprotein CD3 Epsilon Market Size Breakdown by Application (2021-2026)
  14. 3.3.3 Asia-Pacific T Cell Surface Glycoprotein CD3 Epsilon Market Size Breakdown by Application (2021-2026)
  15. 3.3.4 South America T Cell Surface Glycoprotein CD3 Epsilon Market Size Breakdown by Application (2021-2026)
  16. 3.3.5 Middle East and Africa T Cell Surface Glycoprotein CD3 Epsilon Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 T Cell Surface Glycoprotein CD3 Epsilon Industry Trends
  2. 4.2 T Cell Surface Glycoprotein CD3 Epsilon Industry Drivers
  3. 4.3 T Cell Surface Glycoprotein CD3 Epsilon Industry Opportunities and Challenges
  4. 4.4 T Cell Surface Glycoprotein CD3 Epsilon Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by T Cell Surface Glycoprotein CD3 Epsilon Revenue (2021-2026)
  2. 5.2 Global T Cell Surface Glycoprotein CD3 Epsilon Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global T Cell Surface Glycoprotein CD3 Epsilon Key Company Headquarters & Area Served
  4. 5.4 Global T Cell Surface Glycoprotein CD3 Epsilon Company, Product Type & Application
  5. 5.5 Global T Cell Surface Glycoprotein CD3 Epsilon Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global T Cell Surface Glycoprotein CD3 Epsilon Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 T Cell Surface Glycoprotein CD3 Epsilon Players Market Share by Revenue in 2025
  9. 5.6.3 2025 T Cell Surface Glycoprotein CD3 Epsilon Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 GlaxoSmithKline Plc
  2. 6.1.1 GlaxoSmithKline Plc Company Information
  3. 6.1.2 GlaxoSmithKline Plc Business Overview
  4. 6.1.3 GlaxoSmithKline Plc T Cell Surface Glycoprotein CD3 Epsilon Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 GlaxoSmithKline Plc T Cell Surface Glycoprotein CD3 Epsilon Product Portfolio
  6. 6.1.5 GlaxoSmithKline Plc Recent Developments
  7. 6.2 Amgen Inc
  8. 6.2.1 Amgen Inc Company Information
  9. 6.2.2 Amgen Inc Business Overview
  10. 6.2.3 Amgen Inc T Cell Surface Glycoprotein CD3 Epsilon Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Amgen Inc T Cell Surface Glycoprotein CD3 Epsilon Product Portfolio
  12. 6.2.5 Amgen Inc Recent Developments
  13. 6.3 Tiziana Life Sciences Plc
  14. 6.3.1 Tiziana Life Sciences Plc Company Information
  15. 6.3.2 Tiziana Life Sciences Plc Business Overview
  16. 6.3.3 Tiziana Life Sciences Plc T Cell Surface Glycoprotein CD3 Epsilon Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Tiziana Life Sciences Plc T Cell Surface Glycoprotein CD3 Epsilon Product Portfolio
  18. 6.3.5 Tiziana Life Sciences Plc Recent Developments
  19. 6.4 SYNIMMUNE GmbH
  20. 6.4.1 SYNIMMUNE GmbH Company Information
  21. 6.4.2 SYNIMMUNE GmbH Business Overview
  22. 6.4.3 SYNIMMUNE GmbH T Cell Surface Glycoprotein CD3 Epsilon Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 SYNIMMUNE GmbH T Cell Surface Glycoprotein CD3 Epsilon Product Portfolio
  24. 6.4.5 SYNIMMUNE GmbH Recent Developments
  25. 6.5 Numab Innovation AG
  26. 6.5.1 Numab Innovation AG Company Information
  27. 6.5.2 Numab Innovation AG Business Overview
  28. 6.5.3 Numab Innovation AG T Cell Surface Glycoprotein CD3 Epsilon Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Numab Innovation AG T Cell Surface Glycoprotein CD3 Epsilon Product Portfolio
  30. 6.5.5 Numab Innovation AG Recent Developments
  31. 6.6 Meridigen Biotech Co Ltd
  32. 6.6.1 Meridigen Biotech Co Ltd Company Information
  33. 6.6.2 Meridigen Biotech Co Ltd Business Overview
  34. 6.6.3 Meridigen Biotech Co Ltd T Cell Surface Glycoprotein CD3 Epsilon Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Meridigen Biotech Co Ltd T Cell Surface Glycoprotein CD3 Epsilon Product Portfolio
  36. 6.6.5 Meridigen Biotech Co Ltd Recent Developments
  37. 6.7 MacroGenics Inc
  38. 6.7.1 MacroGenics Inc Company Information
  39. 6.7.2 MacroGenics Inc Business Overview
  40. 6.7.3 MacroGenics Inc T Cell Surface Glycoprotein CD3 Epsilon Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 MacroGenics Inc T Cell Surface Glycoprotein CD3 Epsilon Product Portfolio
  42. 6.7.5 MacroGenics Inc Recent Developments
  43. 6.8 F. Hoffmann-La Roche Ltd
  44. 6.8.1 F. Hoffmann-La Roche Ltd Company Information
  45. 6.8.2 F. Hoffmann-La Roche Ltd Business Overview
  46. 6.8.3 F. Hoffmann-La Roche Ltd T Cell Surface Glycoprotein CD3 Epsilon Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 F. Hoffmann-La Roche Ltd T Cell Surface Glycoprotein CD3 Epsilon Product Portfolio
  48. 6.8.5 F. Hoffmann-La Roche Ltd Recent Developments
  49. 6.9 Celgene Corp
  50. 6.9.1 Celgene Corp Company Information
  51. 6.9.2 Celgene Corp Business Overview
  52. 6.9.3 Celgene Corp T Cell Surface Glycoprotein CD3 Epsilon Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Celgene Corp T Cell Surface Glycoprotein CD3 Epsilon Product Portfolio
  54. 6.9.5 Celgene Corp Recent Developments
7 North America
  1. 7.1 North America T Cell Surface Glycoprotein CD3 Epsilon Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America T Cell Surface Glycoprotein CD3 Epsilon Market Size by Country (2021-2026)
  3. 7.3 North America T Cell Surface Glycoprotein CD3 Epsilon Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe T Cell Surface Glycoprotein CD3 Epsilon Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe T Cell Surface Glycoprotein CD3 Epsilon Market Size by Country (2021-2026)
  3. 8.3 Europe T Cell Surface Glycoprotein CD3 Epsilon Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific T Cell Surface Glycoprotein CD3 Epsilon Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific T Cell Surface Glycoprotein CD3 Epsilon Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific T Cell Surface Glycoprotein CD3 Epsilon Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America T Cell Surface Glycoprotein CD3 Epsilon Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America T Cell Surface Glycoprotein CD3 Epsilon Market Size by Country (2021-2026)
  3. 10.3 South America T Cell Surface Glycoprotein CD3 Epsilon Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa T Cell Surface Glycoprotein CD3 Epsilon Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa T Cell Surface Glycoprotein CD3 Epsilon Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa T Cell Surface Glycoprotein CD3 Epsilon Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst